Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04281017 · ClinicalTrials.gov registry record · Phase 4

Effect of Position and Anesthetic Choice in Intraocular Pressure in Robotic GYN (Gynecologic) Oncology Patients

A Phase 4 study of Oncology and Intraocular Pressure, sponsored by University of Florida.

Recruiting
Registry status
Phase 4
Development phase
40
Enrollment target
1
Study location

NCT04281017: Recruiting Phase 4 study of Oncology and Intraocular Pressure, sponsored by University of Florida.

NCT04281017 is a Phase 4 study of Oncology and Intraocular Pressure that is actively recruiting participants, run by University of Florida. The registered enrollment target is 40 participants, below the 526-participant average among 24 other Oncology trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04281017, a Phase 4 study of Oncology and Intraocular Pressure, is actively recruiting participants, sponsored by University of Florida.

RECRUITING
Registry status
Phase 4
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

Steep Trendelenburg positioning and insufflation of the abdominal cavity have shown to increase intra ocular pressure. Different anesthetic techniques can alter intra ocular pressure and a small pilot study showed decrease in Intraocular Pressure (IOP) in robotic case in steep Trendelenburg with IV anesthetics (TIVA). We want to quantify the degree of change in Intraocular Pressure (IOP) in female patients undergoing robotic procedures for cancer. We want to detect the difference in increase of pressure with total IV anesthesia versus conventional balanced anesthesia

Primary Outcome

The degree of change in intra ocular pressure

Interventions

  • DRUG TIVA
  • DRUG Balanced anesthesia

Study Locations (1)

Florida

  • University of Florida - Gainesville

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2020-11-10
Est. Completion 2027-06-18
Phase Phase 4
University of Florida

1,106 total trials

What NCT04281017 shows while recruiting

NCT04281017 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 526-participant average among 24 other Oncology trials with a reported enrollment target (92% lower).

The record links to 2 conditions, with Oncology appearing as the primary indexed condition, and to 2 interventions - of which TIVA is the first listed.

NCT04281017 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT04281017 about?

NCT04281017 is a clinical study titled "Effect of Position and Anesthetic Choice in Intraocular Pressure in Robotic GYN (Gynecologic) Oncology Patients". Steep Trendelenburg positioning and insufflation of the abdominal cavity have shown to increase intra ocular pressure. Different anesthetic techniques can alter intra ocular pressure and a small pilot study showed decrease in Intraocular Pressure (IOP) in robotic case in steep Trendelenburg with IV ...

What is the current status of trial NCT04281017?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2020-11-10. Estimated completion is 2027-06-18.

What conditions does trial NCT04281017 study?

This clinical trial studies the following conditions: Oncology, Intraocular Pressure.

What interventions are being tested in trial NCT04281017?

The interventions under investigation include: TIVA (DRUG), Balanced anesthesia (DRUG).

Who is sponsoring clinical trial NCT04281017?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04281017 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Oncology

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04281017's enrollment target sits among peer trials

40 19th of 24 higher than 5 of 24 other Oncology trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Oncology trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04281017, the US trial registry maintained by the National Library of Medicine. NCT04281017 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.